Bleeding News and Research

RSS

FDA grants Breakthrough Therapy designation to GSK's Promacta/Revolade for treatment of cytopenias

Ligand Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration has granted its partner GlaxoSmithKline plc Breakthrough Therapy designation for Promacta/Revolade (eltrombopag) for the treatment of cytopenias in patients with severe aplastic anemia (SAA) who have had insufficient response to immunosuppressive therapy.

3 Feb 2014

Study outlines agenda to help direct future caffeine dependence research

"I'm a zombie without my morning coffee." "My blood type is Diet Coke." "Caffeine isn't a drug, it's a vitamin." Most people make jokes like these about needing a daily boost from their favorite caffeinated beverage-whether first thing in the morning or to prevent the after-lunch slump.

29 Jan 2014

CCSC identifies 5 routine practices for multidisciplinary teams of critical care professionals

The American Association of Critical-Care Nurses (AACN) — as part of the Critical Care Societies Collaborative (CCSC) — has identified five routine critical care practices that should be questioned because they may not always be necessary and could, in fact, be harmful.

29 Jan 2014

Aspirin prescribed more often for stroke prevention in AF despite of dangerous side effects

Aspirin is still overprescribed for stroke prevention in atrial fibrillation (AF) despite the potential for dangerous side effects, according to research published today.

29 Jan 2014

FDA meeting streamlines pathway to initial U.S. approval of Provectus's PV-10 oncology drug

Provectus Biopharmaceuticals, Inc. (PVCT), a development-stage oncology and dermatology biopharmaceutical company, today announced that it has received the official minutes from the Type C meeting held with the FDA's Division of Oncology Products 2 on December 16, 2013.

27 Jan 2014

TherapeuticsMD starts TX 12-002-HR phase 3 clinical trial for secondary amenorrhea

TherapeuticsMD, Inc., a women's healthcare company, announced today that it has initiated the SPRY Trial, a randomized, placebo-controlled phase 3 clinical trial designed to evaluate the safety and efficacy of TX 12-002-HR, its oral progesterone candidate for secondary amenorrhea, a condition treated to maintain fertility in young premenopausal women.

24 Jan 2014

New drug helps children and young adults who have severe pain from sickle cell disease

Saint Louis University researchers are studying whether ReoPro® (abciximab), a drug currently given to heart patients undergoing angioplasties to open blocked arteries, also could help children and young adults who have severe pain from sickle cell disease.

23 Jan 2014

Researchers report three-fold increase in use of MIS for patients with pancreatic disease

Researchers at University of California, San Diego School of Medicine report a three-fold increase in the use of minimally invasive surgery (MIS) across the nation for patients with pancreatic disease.

16 Jan 2014

Researchers report three-fold increase in use of minimally invasive surgery for pancreatic disease

Researchers at University of California, San Diego School of Medicine report a three-fold increase in the use of minimally invasive surgery across the nation for patients with pancreatic disease. Although adaptation of MIS for this difficult-to-reach gland is recent, the growing trend points to improved patient outcomes, such as reduced bleeding and infections. Now published online, the paper will appear in the March print edition of JAMA Surgery.

15 Jan 2014

Researchers discover key step to stem bleeding, reduce obstruction in blood flow during clot formation

Red blood cells are the body's true shape shifters, perhaps the most malleable of all cell types, transforming - among many other forms -- into compressed discs capable of going through capillaries with diameters smaller than the blood cell itself.

10 Jan 2014

T2HemoStat detection of novel clot behavior could direct therapeutic choices for stroke, heart attack victims

T2 Biosystems, a company developing direct detection products enabling superior diagnostics, announced that scientists from the University of Pennsylvania and T2 Biosystems have published a paper in Blood describing novel clot structure biology detected while testing T2 Bio's T2HemoStat-.

10 Jan 2014

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved Mekinist® (trametinib) for use in combination with Tafinlar® (dabrafenib) for the treatment of patients with unresectable melanoma (melanoma that cannot be removed by surgery) or metastatic melanoma (melanoma which has spread to other parts of the body) with BRAF V600E or V600K mutations.

9 Jan 2014

Bio-inspired adhesive may help surgeons treat congenital heart defects, other heart problems

When a child is born with a heart defect such as a hole in the heart, the highly invasive therapies are challenging due to an inability to quickly and safely secure devices inside the heart.

9 Jan 2014

New study highlights the importance of beta3-integrin protein in cancer research

A protein that has been at the centre of cancer drug design for the last 20 years should not be given up on according to new research from the University of East Anglia (UEA).

6 Jan 2014

Study explores safety and efficacy of scoop and run approach in Philadelphia

A new study from the Perelman School of Medicine at the University of Pennsylvania has found no significant difference in adjusted overall survival rates between gunshot and stabbing (so-called penetrating trauma injuries) victims in Philadelphia whether they were transported to the emergency department by the police department or the emergency medical services division of the fire department.

3 Jan 2014

Viewpoints: Michael Moore finds health law affordability 'a cruel joke'; can more marketing help sell insurance?

Now that the individual mandate is officially here, let me begin with an admission: Obamacare is awful. That is the dirty little secret many liberals have avoided saying out loud for fear of aiding the president's enemies, at a time when the ideal of universal health care needed all the support it could get. ... For many people, the "affordable" part of the Affordable Care Act risks being a cruel joke. ... And yet -- I would be remiss if I didn't say this -- Obamacare is a godsend (Michael Moore, 12/31/13).

3 Jan 2014

Researchers report new gene delivery method that targets tumor blood vessels

Working in mice, researchers at Washington University School of Medicine in St. Louis report developing a gene delivery method long sought in the field of gene therapy: a deactivated virus carrying a gene of interest that can be injected into the bloodstream and make its way to the right cells.

24 Dec 2013

Exposure to images of modified vulvas can significantly influence women's perceptions

Women's perceptions of what is considered normal and desirable female genitalia may be influenced by exposure to modified images, suggests a new study published today (20 December) in BJOG: An International Journal of Obstetrics and Gynaecology.

23 Dec 2013

FDA approves Baxter's FEIBA for prophylactic treatment of hemophilia patients with inhibitors

Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.

From Baxter International Inc. 20 Dec 2013

Satisfaction can be enhanced by improving quality of information received by day-surgery patients

Satisfaction expressed by day-surgery patients can be enhanced by improving the quality of information they receive, and also help assure successful post-operative recovery without the need for outpatient follow-up, according to research reported in the Journal of Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality (NAHQ), www.nahq.org.

19 Dec 2013

Bleeding News and Research

FDA grants Breakthrough Therapy designation to GSK's Promacta/Revolade for treatment of cytopenias

Study outlines agenda to help direct future caffeine dependence research

CCSC identifies 5 routine practices for multidisciplinary teams of critical care professionals

Aspirin prescribed more often for stroke prevention in AF despite of dangerous side effects

FDA meeting streamlines pathway to initial U.S. approval of Provectus's PV-10 oncology drug

TherapeuticsMD starts TX 12-002-HR phase 3 clinical trial for secondary amenorrhea

New drug helps children and young adults who have severe pain from sickle cell disease

Researchers report three-fold increase in use of MIS for patients with pancreatic disease

Researchers report three-fold increase in use of minimally invasive surgery for pancreatic disease

Researchers discover key step to stem bleeding, reduce obstruction in blood flow during clot formation

T2HemoStat detection of novel clot behavior could direct therapeutic choices for stroke, heart attack victims

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

Bio-inspired adhesive may help surgeons treat congenital heart defects, other heart problems

New study highlights the importance of beta3-integrin protein in cancer research

Study explores safety and efficacy of scoop and run approach in Philadelphia

Viewpoints: Michael Moore finds health law affordability 'a cruel joke'; can more marketing help sell insurance?

Researchers report new gene delivery method that targets tumor blood vessels

Exposure to images of modified vulvas can significantly influence women's perceptions

FDA approves Baxter's FEIBA for prophylactic treatment of hemophilia patients with inhibitors

Satisfaction can be enhanced by improving quality of information received by day-surgery patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News